ReviewCell communication and signaling : CCS2026
Tissue-derived small extracellular vesicles in cancer diagnosis and prognosis: current insights and future directions.
Review in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tissue derived extracellular vesicles advance from disease mechanisms to clinical application.Discover nano · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundCancer remains one of the leading causes of human death worldwide. Small extracellular vesicles (sEVs) are nanoscale particles that play important roles in intercellular communication in cancer and represent a valuable source for cancer biomarker discovery. Tissue-derived small extracellular vesicles (Ti-sEVs) are a specific subtype of sEVs and have attracted increasing attention as an emerging research area in cancer diagnostics and therapeutics. Recent progress has highlighted the distinct advantages of Ti-sEVs, including greater cancer specificity, minimal exogenous contamination, enhanced potential for cancer biomarker discovery and understanding tumour microenvironment (TME) dynamics.
methodsThis review summarises recent advancements in the preparation, isolation, and characterization of Ti-sEVs. It further discusses current knowledge of their biological functions within the TME and critically evaluates their emerging application in cancer diagnosis and prognosis.
conclusionTi-sEVs offer unique opportunities for cancer biomarker discovery and translational research. However, key challenges remain, including tissue processing variability, methodological standardization, and technical barriers to clinical implementation. Addressing these issues will be essential to realize the full potential of Ti-sEV-based diagnostics and therapeutics and to guide future research in this rapidly evolving field.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.